Works matching IS 14783223 AND DT 2018 AND VI 38 AND IP 6
Results: 24
Hepatic encephalopathy: Diagnosis and management.
- Published in:
- Liver International, 2018, v. 38, n. 6, p. 966, doi. 10.1111/liv.13752
- By:
- Publication type:
- Article
Hepatotoxicity of immune checkpoint inhibitors: An evolving picture of risk associated with a vital class of immunotherapy agents.
- Published in:
- Liver International, 2018, v. 38, n. 6, p. 976, doi. 10.1111/liv.13746
- By:
- Publication type:
- Article
Time for the dawn of multimodal therapies and the dusk for mono‐therapeutic trials for cholestatic liver diseases?
- Published in:
- 2018
- By:
- Publication type:
- Editorial
Telbivudine associated mitochondrial myopathy.
- Published in:
- 2018
- By:
- Publication type:
- Case Study
Pantoprazole‐induced autoimmune chronic hepatitis.
- Published in:
- Liver International, 2018, v. 38, n. 6, p. 995, doi. 10.1111/liv.13737
- By:
- Publication type:
- Article
Detecting liver injury non‐invasively using hyperpolarized <sup>13</sup>C MRI.
- Published in:
- 2018
- By:
- Publication type:
- Editorial
Cenicriviroc, a cytokine receptor antagonist, potentiates all‐trans retinoic acid in reducing liver injury in cholestatic rodents.
- Published in:
- Liver International, 2018, v. 38, n. 6, p. 1128, doi. 10.1111/liv.13698
- By:
- Publication type:
- Article
Metabolic alterations in a rat model of hepatic ischaemia reperfusion injury: In vivo hyperpolarized <sup>13</sup>C MRS and metabolic imaging.
- Published in:
- Liver International, 2018, v. 38, n. 6, p. 1117, doi. 10.1111/liv.13695
- By:
- Publication type:
- Article
Author response to “Cryptogenic hepatocellular carcinoma (HCC) had worse overall survival of disease than viral HCC patients”.
- Published in:
- 2018
- By:
- Publication type:
- Letter to the Editor
Cryptogenic hepatocellular carcinoma (HCC) had worse overall survival of disease than viral HCC patients.
- Published in:
- 2018
- By:
- Publication type:
- Letter to the Editor
Liver zonation in children with non‐alcoholic fatty liver disease: Associations with dietary fructose and uric acid concentrations.
- Published in:
- Liver International, 2018, v. 38, n. 6, p. 1102, doi. 10.1111/liv.13661
- By:
- Publication type:
- Article
Ethanol‐mediated suppression of IL‐37 licenses alcoholic liver disease.
- Published in:
- Liver International, 2018, v. 38, n. 6, p. 1095, doi. 10.1111/liv.13642
- By:
- Publication type:
- Article
Altered fatty acid‐binding protein 4 (FABP4) expression and function in human and animal models of hepatocellular carcinoma.
- Published in:
- Liver International, 2018, v. 38, n. 6, p. 1074, doi. 10.1111/liv.13639
- By:
- Publication type:
- Article
ePTFE‐TIPS vs repetitive LVP plus albumin for the treatment of refractory ascites in patients with cirrhosis.
- Published in:
- Liver International, 2018, v. 38, n. 6, p. 1036, doi. 10.1111/liv.13615
- By:
- Publication type:
- Article
Liver elastography malignancy prediction score for noninvasive characterization of focal liver lesions.
- Published in:
- Liver International, 2018, v. 38, n. 6, p. 1055, doi. 10.1111/liv.13611
- By:
- Publication type:
- Article
Concomitant nonalcoholic fatty liver disease does not alter the activity, severity or course of primary biliary cholangitis.
- Published in:
- Liver International, 2018, v. 38, n. 6, p. 1110, doi. 10.1111/liv.13644
- By:
- Publication type:
- Article
Dual PPARα/γ agonist saroglitazar improves liver histopathology and biochemistry in experimental NASH models.
- Published in:
- Liver International, 2018, v. 38, n. 6, p. 1084, doi. 10.1111/liv.13634
- By:
- Publication type:
- Article
Impact of hepatitis C virus (HCV) antiviral treatment on the need for liver transplantation (LT).
- Published in:
- Liver International, 2018, v. 38, n. 6, p. 1022, doi. 10.1111/liv.13618
- By:
- Publication type:
- Article
Ledipasvir/sofosbuvir for treatment of hepatitis C virus in sofosbuvir‐experienced, NS5A treatment‐naïve patients: Findings from two randomized trials.
- Published in:
- Liver International, 2018, v. 38, n. 6, p. 1010, doi. 10.1111/liv.13616
- By:
- Publication type:
- Article
The association between steatosis and diabetes with hepatocellular carcinoma in non‐genotype 3 chronic hepatitis C patients.
- Published in:
- Liver International, 2018, v. 38, n. 6, p. 1064, doi. 10.1111/liv.13633
- By:
- Publication type:
- Article
Follow‐up of sustained virological responders with hepatitis C and advanced liver disease after interferon/ribavirin‐free treatment.
- Published in:
- Liver International, 2018, v. 38, n. 6, p. 1028, doi. 10.1111/liv.13629
- By:
- Publication type:
- Article
On‐treatment changes of liver stiffness at week 26 could predict 2‐year clinical outcomes in HBV‐related compensated cirrhosis.
- Published in:
- Liver International, 2018, v. 38, n. 6, p. 1045, doi. 10.1111/liv.13623
- By:
- Publication type:
- Article
Hepatitis delta virus infection in a large cohort of chronic hepatitis B patients in Ethiopia.
- Published in:
- Liver International, 2018, v. 38, n. 6, p. 1000, doi. 10.1111/liv.13607
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Liver International, 2018, v. 38, n. 6, p. 961, doi. 10.1111/liv.13574
- Publication type:
- Article